Pancreatic cancer: a new treatment for pancreatic cancer

Pancreatic cancer: a new treatment for pancreatic cancer

Publish this article.

A new strategy for pancreatic cancer has been developed.

Although pancreatic cancer is a relatively rare type of cancer, pancreatic tumors are considered to be very aggressive and are responsible for a large number of cancer deaths. Researchers have now discovered a new technology to fight this type of cancer.

According to the Cancer Information Service of the German Cancer Research Center (DKFZ), about 19,000 people in Germany develop pancreatic cancer each year. Since there are almost no symptoms in the early stages of the disease, the majority of those infected are diagnosed later. Treatment depends on the extent of the tumor and the general condition of the patient. Experts have now proposed a new treatment method.

One of the deadliest and deadliest cancers

According to a new statement from Ludwig Maximilian University Hospital (LMU), pancreatic cancer is one of the deadliest types of cancer, and therefore it is extensively researched.

Now, a research group led by Professor Sebastian Kobold of the Department of Clinical Pharmacology at the LMU Clinic in Munich has found a way to efficiently combat this malignancy, at least in the laboratory.

The researchers’ findings were recently announced in the journal Nature Biomedical Engineering.

The chances of survival are slim.

According to experts, anyone with a pancreatic tumor has a low chance of survival. Despite all medical efforts, only ten percent of patients survive five years after diagnosis

This does not discourage researchers and they continue to look for new ways to improve the situation. Sebastian Kobold adds: “There, immunotherapy is treated like hot iron in a fire, and we know from preclinical studies that T cells are in the immune system. Short letter from Bulgarian Business Journal.